Skip to main content
Caplight Logo









Remiges Ventures

Remiges Ventures

Seattle, Washingtonremigesventures.com

Overview

Remiges Ventures is a cross-border venture capital firm that focuses on company creation and investments in early-stage drug discovery and development companies in the United States and Japan.

Year Founded

2014

Portfolio Companies

18

Investments

Remiges Ventures investments
CompanyDateStageLead
Cyrano TherapeuticsJan 2024Series BCo-investor
Immunis, Inc.Jan 2025Series A ExtensionCo-investor
Viage TherapeuticsJan 2022SeedLead
InFlectis BioScienceJun 2016Series ALead
OMEICOS TherapeuticsNov 2018Series CCo-investor
Book a demo to see all 18 portfolio companies

For institutional investors. Book with your work email.

Key People

Hiroshi Tamada

Chief Medical Officer, Scientific Advisor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Remiges Ventures based?

Remiges Ventures is headquartered in Seattle, Washington, United States.

When was Remiges Ventures founded?

Remiges Ventures was founded in 2014.

How many portfolio companies does Remiges Ventures have?

Remiges Ventures has 18 portfolio companies in Caplight's dataset.

What are some companies in Remiges Ventures's portfolio?

Portfolio companies visible on Caplight include Cyrano Therapeutics, Immunis, Inc., Viage Therapeutics, InFlectis BioScience, OMEICOS Therapeutics.

What was Remiges Ventures's most recent investment shown here?

Remiges Ventures's most recent investment in this portfolio sample was in Immunis, Inc. in 2025.

What sectors does Remiges Ventures focus on?

Remiges Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software.

What company stages does Remiges Ventures focus on?

Remiges Ventures typically invests at the Early stage.

What is Remiges Ventures's AUM?

Remiges Ventures's assets under management are estimated between $50.0M and $100.0M.

Firmographic Details

HeadquartersSeattle, Washington
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?